Tag: pharmaceutical
-
U.S. Justice Department subpoenas Taro over generic drug pricing
By Sarah N. Lynch WASHINGTON (Reuters) – Taro Pharmaceutical Industries Ltd and two of its senior officers received grand jury subpoenas last week in connection with a federal antitrust investigation into generic drug pricing, the company disclosed. The company, which is headquartered in Israel, said late on Friday it received subpoenas on Thursday from the…
-
GSK, Google parent company to make bioelectronic medicine
LONDON (AP) — Pharmaceutical giant GlaxoSmithKline is forming a joint venture with a unit of Google’s parent that will invest 540 million pounds ($714 million) in the relatively new field of bioelectronic medicine.
-
Sumo-Tributes pour in for Chiyonofuji following wrestler’s death
Japan mourned the death of legendary sumo wrestler Chiyonofuji on Monday, a day after the 31-time tournament champion succumbed to pancreatic cancer in a Tokyo hospital at the age of 61. The muscular wrestler, who ran the Kokonoe stable, is third on the all-time list for the most championship wins behind Hakuho (37) and Taiho…
-
Allergan profit beats estimates, share buybacks planned
The Dublin drugmaker on Tuesday said the planned $40 billion sale of its generics business to Teva Pharmaceutical Industries will close next month and that it will use $8 billion of the money to pay down company debt. Since the U.S. government torpedoed the merger, a deal that would have relocated Pfizer's legal domicile to…
-
Vaccines put brakes on yellow fever outbreaks, more may pop up: WHO
By Tom Miles GENEVA (Reuters) – A major yellow fever outbreak in Angola and two smaller flare-ups in Uganda and Congo are largely under control but countries have been warned to be vigilant in case the disease pops up elsewhere, the World Health Organization (WHO) said on Tuesday. Yellow fever is hard to spot early…
-
China probes drugmakers over production methods
Three Chinese drugmakers are under investigation for crimes including using counterfeit medicines, the industry watchdog said, as China cracks down on shoddy practices in the world’s second-biggest drugs market. The China Food and Drug Administration said it was investigating Hebei Yongfeng Yaoye, a subsidiary of Hong Kong-listed CSPC Pharmaceutical Group, as well as Gansu Dadeli…
-
BioMarin drug fails to show inattention, mood benefit in study
BioMarin Pharmaceutical Inc’s drug met a study’s main goal of reducing a toxic buildup of an amino acid in the blood of patients with a genetic disorder, but did not show enough benefit in related inattention and mood complications. BioMarin’s shares fell as much as 6 percent in early trading on Monday after the company…
-
Brexit is the wrong prescription, says European pharma industry
By Ben Hirschler LONDON (Reuters) – Britain's departure from the European Union would threaten scientific research and jeopardize the 28-nation bloc's system of drug regulation, the European pharmaceutical industry said on Wednesday. The declaration is the clearest statement yet on the issue by an industry that includes EU-based players such as Britain's GlaxoSmithKline and AstraZeneca,…
-
Proving Zika guilty: A long and painstaking task
By Kate Kelland LONDON,(Reuters) – Evidence is building for the theory that Zika can cause newborn brain defects and the World Health Organization is promising more answers in weeks, but nailing a definitive link will be neither simple nor swift. Picking apart numerous potential connections between mothers who show evidence of infection with the mosquito-borne…
-
WHO chief ‘confident’ Olympics will be safe despite Zika
Brasília (AFP) – The head of the World Health Organization expressed confidence that Brazil can host the Rio Olympics safely despite the Zika threat, while warning of a long battle against the mosquito-borne virus. Margaret Chan praised the Brazilian government's efforts to stamp out mosquitoes and its coordination with various international bodies, including the WHO…